Investment Stage

Focus Areas

About Investor

Michael Aberman is a General Partner at Regeneron Ventures, focusing on investments in Pharmaceuticals and BioTech at the Seed and Series A stages, with investment ranges between $100K and $2.0M. His professional background includes venture capital investing with a strong emphasis on life sciences companies in the New York City area. Aberman is dedicated to supporting founders who are developing innovative treatments and technologies in the pharmaceutical and biotechnology sectors. He brings scientific expertise and investment acumen to his role in nurturing early-stage companies.